A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 309 participants.

Also called NCT02550288

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 309 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02550288
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02550288. Randomized; double masking; primary purpose treatment. Start 2015-09-29 (actual); primary completion 2016-05-30 (actual). Results posted on 2017-06-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
Condition
Hypercholesterolemia
Intervention (Drug)
Ezetimibe 10 mg
Intervention (Drug)
Atorvastatin 10 mg
Intervention (Drug)
Placebo for Ezetimibe 10 mg tablet
Intervention (Drug)
Placebo for Atorvastatin 10 mg capsule
Intervention (Behavioral)
Diet control/Daily Exercise
Lead sponsor
Organon and Co (class: industry)

Record details

Record id
cardio:ct-nct02550288
Content hash
2e0b6d54a1b30b4d4e150c5fa615146ad73131886767a96cc4d8c3143bddb37f